Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

9.4%

3 terminated out of 32 trials

Success Rate

89.3%

+2.8% vs benchmark

Late-Stage Pipeline

22%

7 trials in Phase 3/4

Results Transparency

24%

6 of 25 completed with results

Key Signals

6 with results89% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (19)
P 1 (1)
P 2 (1)
P 3 (2)
P 4 (5)

Trial Status

Completed25
Unknown3
Terminated3
Not Yet Recruiting1

Trial Success Rate

89.3%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT07381569Not ApplicableNot Yet RecruitingPrimary

To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion

NCT01615731Not ApplicableCompletedPrimary

Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks

NCT00383032Not ApplicableCompletedPrimary

Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction

NCT02485444Phase 4CompletedPrimary

Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion

NCT02279914Not ApplicableCompletedPrimary

Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial

NCT04290832Not ApplicableTerminatedPrimary

Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa

NCT03080493Phase 4CompletedPrimary

Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial

NCT00816751Not ApplicableCompletedPrimary

Paracervical Versus Intracervical Lidocaine

NCT00188071Not ApplicableCompletedPrimary

Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen

NCT02318212CompletedPrimary

Dilapan-S / Dilasoft E-Registry in Induced Abortion

NCT01356927CompletedPrimary

Same-day Long-acting Reversible Contraception for Medication Abortion

NCT02277249Not ApplicableCompletedPrimary

Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion

NCT02480543Phase 4UnknownPrimary

Different Routes of Misoprostol Prior to First Trimester Surgical Abortion

NCT01751087Not ApplicableCompletedPrimary

Cervical Preparation Before Dilation and Evacuation

NCT00177333Phase 4CompletedPrimary

Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens

NCT02048098Phase 3CompletedPrimary

Misoprostol for Second Trimester Termination of Pregnancy

NCT01541293Phase 1CompletedPrimary

Intrauterine Lidocaine for Laminaria

NCT00969982Not ApplicableCompletedPrimary

Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))

NCT00784186Not ApplicableCompletedPrimary

Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial

NCT01597726Not ApplicableCompletedPrimary

Cervical Priming Before Dilation & Evacuation

Scroll to load more

Research Network

Activity Timeline